Chemical formula: C₉H₁₇NO₂ Molecular mass: 171.237 g/mol PubChem compound: 3446
Gabapentin readily enters the brain and prevents seizures in a number of animal models of epilepsy. Gabapentin binds with high affinity to the α2δ (alpha-2-delta) subunit of voltage-gated calcium channels and it is proposed that binding to the α2δ subunit may be involved in gabapentin’s anti-seizure effects in animals.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02BF01 | Gabapentin | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BF Gabapentinoids |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| NEURONTIN Capsule, hard | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| NEURONTIN Capsule / Film-coated tablet / Solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Gabapentin is an active ingredient of these brands:
Albania (AL)Brazil (BR)Canada (CA)Ecuador (EC)France (FR)Israel (IL)Malta (MT)Mexico (MX)Netherlands (NL)South Africa (ZA)Spain (ES)Turkey (TR)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
